Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-05-18 Purchase | 2022-05-19 4:30 pm | Aprea Therapeutics Inc. | APRE | SCHADE CHRISTIAN S Chairman & CEO | 37,500 | $0.6433 | $24,124 | 303,616 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-20 Option Award | 2024-06-21 4:20 pm | N/A 2034-06-19 | Omega Therapeutics Inc. | OMGA | SCHADE CHRISTIAN S Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2024-05-09 Option Award | 2024-05-13 4:38 pm | N/A N/A | INTEGRA LIFESCIENCES HOLDINGS CORP | IART | SCHADE CHRISTIAN S Director | 8,696 | $0 | 63,503 (Direct) | View |
| 2023-07-10 Option Award(A) | 2024-02-09 5:00 pm | N/A 2033-07-09 | Omega Therapeutics Inc. | OMGA | SCHADE CHRISTIAN S Director | 36,713 | $0 | 36,713 (Direct) | View |
| 2024-02-07 Option Award | 2024-02-09 4:57 pm | N/A 2034-02-06 | Omega Therapeutics Inc. | OMGA | SCHADE CHRISTIAN S Director | 512,848 | $0 | 512,848 (Direct) | View |
| 2023-07-10 Option Award | 2023-07-12 4:21 pm | N/A 2023-07-09 | Omega Therapeutics Inc. | OMGA | SCHADE CHRISTIAN S Director | 36,713 | $0 | 36,713 (Direct) | View |
| 2023-05-12 Option Award | 2023-05-16 4:18 pm | N/A N/A | INTEGRA LIFESCIENCES HOLDINGS CORP | IART | SCHADE CHRISTIAN S Director | 4,486 | $0 | 54,807 (Direct) | View |
| 2022-07-28 Option Award | 2022-08-01 5:06 pm | N/A 2032-07-28 | Aprea Therapeutics Inc. | APRE | SCHADE CHRISTIAN S Director | 80,000 | $0 | 317,846 (Direct) | View |
| 2022-06-03 Tax Withholding | 2022-06-07 5:05 pm | N/A N/A | Aprea Therapeutics Inc. | APRE | SCHADE CHRISTIAN S Chairman & CEO | 65,770 | $0.805 | 237,846 (Direct) | View |
| 2022-05-13 Option Award | 2022-05-17 4:44 pm | N/A N/A | INTEGRA LIFESCIENCES HOLDINGS CORP | IART | SCHADE CHRISTIAN S Director | 4,721 | $0 | 50,321 (Direct) | View |
| 2022-03-10 Option Award | 2022-03-14 5:03 pm | N/A 2032-03-10 | Aprea Therapeutics Inc. | APRE | SCHADE CHRISTIAN S Chairman & CEO | 527,800 | $0 | 693,816 (Direct) | View |
| 2022-02-25 Tax Withholding | 2022-03-01 5:02 pm | N/A N/A | Aprea Therapeutics Inc. | APRE | SCHADE CHRISTIAN S Chairman & CEO | 21,644 | $1.74 | 166,016 (Direct) | View |
| 2021-05-14 Option Award | 2021-05-17 4:23 pm | N/A N/A | INTEGRA LIFESCIENCES HOLDINGS CORP | IART | SCHADE CHRISTIAN S Director | 3,426 | $0 | 45,600 (Direct) | View |
| 2021-02-25 Option Award | 2021-03-01 7:05 pm | N/A 2031-02-25 | Aprea Therapeutics Inc. | APRE | SCHADE CHRISTIAN S Chairman & CEO | 494,500 | $0 | 516,660 (Direct) | View |
| 2020-05-13 Option Award | 2020-05-15 4:07 pm | N/A N/A | INTEGRA LIFESCIENCES HOLDINGS CORP | IART | SCHADE CHRISTIAN S Director | 5,009 | $0 | 42,174 (Direct) | View |
| 2020-03-24 Option Award | 2020-03-26 5:02 pm | N/A 2030-03-24 | Aprea Therapeutics Inc. | APRE | SCHADE CHRISTIAN S President & CEO | 127,000 | $0 | 127,000 (Direct) | View |